Prelude Therapeutics IncorporatedPRLDNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-56.37M
↑ 15% vs avg
Percentile
P57
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
$-66.24M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-56.37M | +45.6% |
| 2024 | $-103.65M | +6.3% |
| 2023 | $-110.58M | -27.5% |
| 2022 | $-86.75M | -1.0% |
| 2021 | $-85.85M | -83.5% |
| 2020 | $-46.80M | -77.0% |
| 2019 | $-26.45M | -96.1% |
| 2018 | $-13.48M | - |